These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 7769262

  • 1. Improved diagnosis of mastocytosis by measurement of the major urinary metabolite of prostaglandin D2.
    Morrow JD, Guzzo C, Lazarus G, Oates JA, Roberts LJ.
    J Invest Dermatol; 1995 Jun; 104(6):937-40. PubMed ID: 7769262
    [Abstract] [Full Text] [Related]

  • 2. Evidence that histamine is the causative toxin of scombroid-fish poisoning.
    Morrow JD, Margolies GR, Rowland J, Roberts LJ.
    N Engl J Med; 1991 Mar 14; 324(11):716-20. PubMed ID: 1997836
    [Abstract] [Full Text] [Related]

  • 3. Increased levels of prostaglandin D(2) suggest macrophage activation in patients with primary pulmonary hypertension.
    Robbins IM, Barst RJ, Rubin LJ, Gaine SP, Price PV, Morrow JD, Christman BW.
    Chest; 2001 Nov 14; 120(5):1639-44. PubMed ID: 11713147
    [Abstract] [Full Text] [Related]

  • 4. Simplification of the mass spectrometric assay for the major urinary metabolite of prostaglandin D2.
    Awad JA, Morrow JD, Roberts LJ.
    J Chromatogr; 1993 Jul 23; 617(1):124-8. PubMed ID: 8376525
    [Abstract] [Full Text] [Related]

  • 5. Quantification of the major urinary metabolite of prostaglandin D2 by a stable isotope dilution mass spectrometric assay.
    Morrow JD, Prakash C, Awad JA, Duckworth TA, Zackert WE, Blair IA, Oates JA, Roberts LJ.
    Anal Biochem; 1991 Feb 15; 193(1):142-8. PubMed ID: 2042739
    [Abstract] [Full Text] [Related]

  • 6. Detection of the major urinary metabolite of prostaglandin D2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation.
    Awad JA, Morrow JD, Roberts LJ.
    J Allergy Clin Immunol; 1994 May 15; 93(5):817-24. PubMed ID: 8182221
    [Abstract] [Full Text] [Related]

  • 7. Increased formation of thromboxane in vivo in humans with mastocytosis.
    Morrow JD, Oates JA, Roberts LJ, Zackert WE, Mitchell TA, Lazarus G, Guzzo C.
    J Invest Dermatol; 1999 Jul 15; 113(1):93-7. PubMed ID: 10417625
    [Abstract] [Full Text] [Related]

  • 8. Metabolic fate of endogenously synthesized prostaglandin D2 in a human female with mastocytosis.
    Roberts LJ, Sweetman BJ.
    Prostaglandins; 1985 Sep 15; 30(3):383-400. PubMed ID: 3864190
    [Abstract] [Full Text] [Related]

  • 9. Measurement of urinary N tau-methylhistamine excretion: correlation of a newly developed radioimmunoassay (RIA) with gas chromatography mass spectrometry (GCMS).
    Oosting E, Keyzer JJ.
    Agents Actions; 1991 May 15; 33(1-2):215-7. PubMed ID: 1897442
    [Abstract] [Full Text] [Related]

  • 10. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
    Butterfield JH, Weiler CR.
    Int Arch Allergy Immunol; 2008 May 15; 147(4):338-43. PubMed ID: 18622141
    [Abstract] [Full Text] [Related]

  • 11. On the role of PGD2 metabolites as markers of mast cell activation in asthma.
    O'Sullivan S.
    Acta Physiol Scand Suppl; 1999 Apr 15; 644():1-74. PubMed ID: 10352758
    [Abstract] [Full Text] [Related]

  • 12. Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites.
    Keyzer JJ, de Monchy JG, van Doormaal JJ, van Voorst Vader PC.
    N Engl J Med; 1983 Dec 29; 309(26):1603-5. PubMed ID: 6646186
    [Abstract] [Full Text] [Related]

  • 13. A stable isotope dilution mass spectrometric assay for the major urinary metabolite of PGD2.
    Morrow JD, Prakash C, Duckworth TA, Zackert WE, Blair IA, Oates JA, Roberts LJ.
    Adv Prostaglandin Thromboxane Leukot Res; 1991 Dec 29; 21A():315-8. PubMed ID: 1825560
    [Abstract] [Full Text] [Related]

  • 14. Metabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteer.
    Liston TE, Roberts LJ.
    J Biol Chem; 1985 Oct 25; 260(24):13172-80. PubMed ID: 3863815
    [Abstract] [Full Text] [Related]

  • 15. Excretion of urinary histamine and N-tele methylhistamine in patients with gastrointestinal food allergy compared to non-allergic controls during an unrestricted diet and a hypoallergenic diet.
    Raithel M, Hagel A, Albrecht H, Zopf Y, Naegel A, Baenkler HW, Buchwald F, Schultis HW, Kressel J, Hahn EG, Konturek P.
    BMC Gastroenterol; 2015 Apr 01; 15():41. PubMed ID: 25888445
    [Abstract] [Full Text] [Related]

  • 16. Effects of isoprenaline and terbutaline on urinary excretion of histamine and its two main metabolites in systemic mastocytosis.
    van Doormaal JJ, Idema IG, de Monchy JG, Breukelman H, Keyzer JJ, Doorenbos H.
    Agents Actions; 1986 Apr 01; 18(1-2):269-72. PubMed ID: 3728212
    [Abstract] [Full Text] [Related]

  • 17. Analytical and clinical validation of an LC-MS/MS method for urine leukotriene E4: A marker of systemic mastocytosis.
    Lueke AJ, Meeusen JW, Donato LJ, Gray AV, Butterfield JH, Saenger AK.
    Clin Biochem; 2016 Sep 01; 49(13-14):979-82. PubMed ID: 26908217
    [Abstract] [Full Text] [Related]

  • 18. The measurement of leukotrienes in urine as diagnostic option in systemic mastocytosis.
    Raithel M, Zopf Y, Kimpel S, Naegel A, Molderings GJ, Buchwald F, Schultis HW, Kressel J, Hahn EG, Konturek P.
    J Physiol Pharmacol; 2011 Aug 01; 62(4):469-72. PubMed ID: 22100848
    [Abstract] [Full Text] [Related]

  • 19. Value of urinary N-methylhistamine measurements in childhood mastocytosis.
    Van Gysel D, Oranje AP, Vermeiden I, de Lijster de Raadt J, Mulder PG, van Toorenenbergen AW.
    J Am Acad Dermatol; 1996 Oct 01; 35(4):556-8. PubMed ID: 8859283
    [Abstract] [Full Text] [Related]

  • 20. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.
    Divekar R, Butterfield J.
    Allergy; 2015 Oct 01; 70(10):1230-8. PubMed ID: 26095439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.